{"width":"100%","title":"Troms\u00f8 Aorta 2024 \u304b\u3089\u306e\u5831\u544a\u3000\uff5evEDS\u306b\u304a\u3051\u308b\u85ac\u7269\u7ba1\u7406\uff5e","categories":["\u30aa\u30f3\u30e9\u30a4\u30f3\u30bb\u30df\u30ca\u30fc","\u8840\u7ba1\u578b\u30a8\u30fc\u30e9\u30b9\u30fb\u30c0\u30f3\u30ed\u30b9\u75c7\u5019\u7fa4\uff08vEDS\uff09","\u5faa\u74b0\u5668","\u85ac"],"type":"rich","version":"1.0","author_url":"https://blog.hatena.ne.jp/marfan-info/","author_name":"marfan-info","image_url":null,"height":"190","published":"2025-01-28 22:26:02","provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2025%2F01%2F28%2F222602\" title=\"Troms\u00f8 Aorta 2024 \u304b\u3089\u306e\u5831\u544a\u3000\uff5evEDS\u306b\u304a\u3051\u308b\u85ac\u7269\u7ba1\u7406\uff5e - \u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_url":"https://marfan-info.hatenablog.com/","url":"https://marfan-info.hatenablog.com/entry/2025/01/28/222602","description":"Troms\u00f8 Aorta 2024 Recap with Dr. Kim Eagle 13:03-15:02 One of the really interesting talks that we heard in Troms\u00f8 was a trial that is looking at the management of patients with vascular EDS. This was a small study, I think less than 60 patients, who were randomized to receive, in addition to a beta\u2026","provider_name":"Hatena Blog","blog_title":"\u6d77\u5916\u30de\u30eb\u30d5\u30a1\u30f3\u60c5\u5831 | Global Marfan Updates"}